source
- Weekly roundup highlights LGBTQ+ leadership in biopharma and reports of a Novo Nordisk hackThe latest Endpoints Weekly newsletter was published on June 20, 2026, coinciding with the summer solstice in the northern hemisphere. The issue spotlights the growing visibility of LGBTQ+ leaders…
- Daraxonrasib doubles median survival in pancreatic cancer trial, FDA grants early accessAn international study presented at the American Society of Clinical Oncology meeting in Chicago showed that patients with pancreatic cancer who received daraxonrasib lived an average of 13.2 month…